#United States #Dividend #Burlington #Labcorp #Stockholder

Labcorp Announces Quarterly Cash Dividend

Labcorp Holdings Inc. (NYSE: LH), a leading global provider of innovative and comprehensive laboratory services, has made a significant announcement for its investors. The company has declared a quarterly cash dividend amounting to $0.72 per share of common stock. This announcement was made public on July 9, 2026, and has generated considerable interest among stakeholders.

The Board of Directors made this decision in recognition of the company's strong financial performance and commitment to returning value to its shareholders. The declared dividend will be distributed on September 11, 2026, to all stockholders who are on record by the close of business on August 28, 2026. This aligns with Labcorp's ongoing strategy to maintain shareholder engagement and confidence through consistent dividend payments.

Labcorp's Profile

Labcorp operates as a global leader within the laboratory services industry, providing critical insights that empower healthcare professionals, researchers, and patients to make informed and confident health decisions. With a dedicated workforce of approximately 71,000 employees, Labcorp serves clients across nearly 100 countries. The company's diagnostic capabilities have supported over 85% of new drugs and therapeutic products that received FDA approval in 2025, evidencing its pivotal role in the healthcare and pharmaceuticals landscape.

The sheer volume of over 750 million tests conducted for patients around the world underscores Labcorp's commitment to improving health outcomes and advancing scientific understanding through rigorous diagnostics and drug development capabilities.

Labcorp's consistent dividends are a testament to its robust financial health and solid business model, reinforcing the trust of investors in its long-term growth prospects. As Labcorp continues to innovate and enhance its laboratory services, the company is poised to play an increasingly vital role in the future of healthcare delivery.

Investors looking for stability and reliable returns will find Labcorp's dividend declaration a noteworthy highlight in the current economic landscape, as it reflects the company’s resilience and ongoing commitment to shareholder value.

In conclusion, Labcorp remains dedicated to its mission of transforming health through innovation and exploration, ensuring that its stakeholders are prioritized every step of the way. For more information on Labcorp and its services, visit www.labcorp.com.